Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects?

Psychiatry Research

Volumn 104, Issue 3, 2001, Pages 227-237

  Del Ben, Cristina M ^a   Vilela, José A A ^a   Hetem, Luiz A B ^a   Guimarães, Francisco S ^a   Graeff, Frederico G ^a   Zuardi, Antonio W ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Bodily symptoms; Panic disorder; Public speaking; Skin conductance response

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEAR; FEMALE; HUMAN; MALE; MOOD; PANIC; PRIORITY JOURNAL; RATING SCALE; SKIN CONDUCTANCE; SPEECH; TASK PERFORMANCE; VISION;

ADOLESCENT; ADULT; ANXIETY; CONDITIONING (PSYCHOLOGY); FEAR; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; PANIC DISORDER; VERBAL BEHAVIOR;

EID: 0035976653     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00312-2     Document Type: Article

References (49)

1. Relaxation-induced panic (RIP): When resting isn't peaceful
2. 5-HT and human anxiety. Evidence from studies using acute tryptophan depletion
3. 2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline
4. Ethoexperimental approaches to the biology of emotion
5. Physiological and psychological measures in anxious patients
6. Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal
7. Social phobia: Diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
8. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam
9. 5-HT and mechanisms of defence
10. 5-HT subtypes and the modulation of aversion
11. Testing 5-HT theories of anxiety in normal volunteers
12. Early clinical experience with ritanserin in neurotic patients
13. Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin
14. Social phobia in the general population: Prevalence and sociodemographic profile
15. The development of a scale to measure fear
16. The aversive system, 5HT and panic attacks
17. Animal model of aversion
18. Brain defense systems and anxiety
19. Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety
20. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals
21. Role of 5-HT in stress, anxiety and depression
22. Role of the amygdala and periaqueductal gray in anxiety and panic
23. Effect of metergoline on human anxiety
24. Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: Influence of gender, instructions, personality and placebo
25. Ritanserin facilitates anxiety in simulated public-speaking paradigm
26. The effects of ritanserin on aversive classical conditioning in humans
27. Addition of D-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder - A case report
28. Effect of D-fenfluramine on human experimental anxiety
29. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination
30. Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls
31. Psychophysiological response patterns in panic disorder
32. A pilot study of ritanserin (a selective serotonin-2 receptor antagonist) in panic disorder and agoraphobia
33. A model of panic and agoraphobic development
34. The definition and psychopharmacology of spontaneous panic and phobia
35. Panic disorder - A malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter?
36. Simulated public speaking as a model of clinical anxiety
37. D-Fenfluramine in panic disorder: A dual role for 5-hydroxytryptamine
38. The midbrain and pain
39. The action of sedatives on brainstem oculomotor systems in man
40. Anxiety induced by simulated public speaking and Stroop colour word test in healthy subjects: Effects of different trait-anxiety levels
41. Normative data for the personal report of confidence as a speaker
42. Anti-aversive role of serotonin in the dorsal periaqueductal grey matter
43. Controlling panic attacks with fenfluramine
44. Setting diagnostic thresholds for social phobia: Considerations from a community survey of social anxiety
45. Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification
46. Effects of ipsapirone and cannabidiol on human experimental anxiety
47. Estudo transcultural de uma escala de auto-avaliação para estados subjetivos